ALPS Group Inc Ordinary Share (NASDAQ:ALPS – Get Free Report) was the recipient of a significant growth in short interest in August. As of August 14th, there was short interest totaling 26,467 shares, a growth of 61.6% from the July 30th total of 16,382 shares. Based on an average daily volume of 51,884 shares, the short-interest ratio is currently 0.5 days. Approximately 0.0% of the company’s stock are short sold.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of ALPS Group Inc Ordinary Share in a research report on Monday, July 6th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, ALPS Group Inc Ordinary Share presently has an average rating of “Sell”.
Read Our Latest Stock Report on ALPS Group Inc Ordinary Share
ALPS Group Inc Ordinary Share Trading Down 7.8%
About ALPS Group Inc Ordinary Share
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
Featured Stories
- Five stocks we like better than ALPS Group Inc Ordinary Share
- The SaaSpocalypse Trade Is Cracking, and These 5 Stocks Are Leading Higher
- Microsoft’s Split Verdict Tests Investing Without a Fed Safety Net
- Broadcom’s Earnings Test Comes With a Higher Bar After NVIDIA’s Blowout
- Palo Alto’s Rally Has One Big Problem Ahead of Earnings
Receive News & Ratings for ALPS Group Inc Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Group Inc Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.
